Design, synthesis and biological evaluation of PROteolysis-TArgeting Chimeric (PROTAC) molecules as anticancer agents

Project description

Proteolysis-targeting chimeric technology in the development of anticancer drugs

Fields of science

• medical and health sciences › basic medicine › medicinal chemistry
• medical and health sciences › health sciences
• medical and health sciences › basic medicine › pharmacology and pharmacy › drug resistance
• medical and health sciences › clinical medicine › oncology
• natural sciences › biological sciences › biochemistry › biomolecules › proteins › enzymes

Programme(s)

• H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions Main Programme
• H2020-EU.1.3.2. - Nurturing excellence by means of cross-border and cross-sector mobility

Topic(s)

• MSCA-IF-2020 - Individual Fellowships

Call for proposal

H2020-MSCA-IF-2020

See other projects for this call

Funding Scheme

MSCA-IF-EF-ST - Standard EF

Coordinator

FUNDACION UNIVERSITARIA SAN PABLO-CEU

Net EU contribution

€ 172 932,48

Address

C Isaac Peral 58
28040 Madrid
Spain

Region

Comunidad de Madrid › Comunidad de Madrid › Madrid

Activity type

Higher or Secondary Education Establishments

Links

Other funding

€ 172 932,48